Status | Study |
RECRUITING |
Study Name: An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer Condition: Lung Adenocarcinoma Date: 2022-09-12 Interventions: Given IV |
Completed |
Study Name: EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Condition: Lung Adenocarcinoma Metastatic Date: 2016-11-23 Interventions: Genetic: LC-RT-PCR and NGS highly sensitive PCR vs. multiplex targeted-resequencing |
Recruiting |
Study Name: A+C in Metastatic Lung Adenocarcinoma Cancer Condition: Lung Adenocarcinoma Metastatic Date: 2016-10-24 Interventions: Drug: Crizotinib, bevacizumab Eligible patients with ALK translocation or ROS1 translocation or MET ampl |
Not yet recruiting |
Study Name: Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial Condition: Lung Adenocarcinoma Date: 2016-10-15 Interventions: Drug: Pemetrexed plus carboplatin combined with gefitinib |
Recruiting |
Study Name: Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma Condition: Lung Adenocarcinoma Date: 2016-09-08 Interventions: Other: biopsies The biopsies of lung tumour samples will be analysed by immunochemistry (IHC), western b |
Not yet recruiting |
Study Name: Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas Condition: Metastatic Lung Adenocarcinomas Date: 2016-08-24 Interventions: Other: Non intervention. Observation Study |
Recruiting |
Study Name: Tepotinib Phase II Study in Lung Adenocarcinoma Harbouring MET Exon 14 (METex14) Skipping Alterations Condition: Lung Adenocarcinoma Stage IIIB/IV Date: 2016-07-29 Interventions: Drug: tepotinib Subjects received 500 mg of tepotinib tablet once daily orally during each 21 day cycle |
Active, not recruiting |
Study Name: Molecular Analysis of 150 Lung Adenocarcinoma Condition: Lung Adenocarcinoma Date: 2016-07-20 Interventions: Genetic: Sequencing Tumour samples are coming from routine histopathological procedure. They are used wi |
Recruiting |
Study Name: Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma Condition: Adenocarcinoma of Lung Date: 2016-06-15 Interventions: Drug: recombinant human endostatin |
Recruiting |
Study Name: Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma Condition: Adenocarcinoma of Lung (Disorder) Date: 2016-03-30 Interventions: Genetic: Sequencing of ctDNA in plasma Sequencing of ctDNA in plasma |